Adrafinil
OTHER NAME(S): 2-((Diphenylmethyl)Sulfinyl)-N-Hydroxyacetamide, Adrafinilum, Benzhydryl Sulfinyl Acetyl Hydroxamic Acid, CRL-40028, Olmifon, 2-benzhydrylsulfinyl-N-hydroxyacetamide, Adrafinil
Overview
Adrafinil is a stimulant related to the drug modafinil (Provigil). It's found in some supplements called nootropics, which are marketed for memory or attention.
Adrafinil has effects similar to modafinil, which is a prescription drug that is used to treat narcolepsy.
People use adrafinil for aging, athletic performance, mental alertness, obesity, opioid withdrawal, and many other conditions, but there is no good scientific evidence to support these uses. It might also be unsafe.
Adrafinil is banned by the World Anti-Doping Agency (WADA).
Uses
We currently have no information for Adrafinil overview.
Side Effects
When taken by mouth: Adrafinil is possibly unsafe. It might lead to serious heart or psychiatric-related side effects. It may also be addictive.
Precautions
When taken by mouth: Adrafinil is possibly unsafe. It might lead to serious heart or psychiatric-related side effects. It may also be addictive.
Pregnancy and breast-feeding: Adrafinil is possibly unsafe when taken by mouth while pregnant or breast-feeding. It might cause a miscarriage or lead to developmental problems for the infant. Avoid use.
Heart conditions: Adrafinil is a stimulant that might cause irregular heartbeat or increase blood pressure. This might worsen existing heart conditions. People with heart conditions should avoid use.
Elderly people: Elderly people might be more likely to experience serious side effects from adrafinil.
High blood pressure: People with high blood pressure should avoid adrafinil. It might increase blood pressure even more.
Liver disease: Adrafinil is processed in the liver. People with liver disease might be unable to process it properly. This might increase the risk for side effects.
A mental disorder marked by hallucinations and delusion (psychosis): Adrafinil might make existing psychosis worse. Avoid use.
Interactions
Moderate Interaction
Be cautious with this combination
- Modafinil (Provigil) interacts with AdrafinilAdrafinil has effects similar to the drug modafinil. Taking adrafinil with modafinil might increase the effects and side effects of modafinil.
- Medications for depression (MAOIs) interacts with AdrafinilAdrafinil has effects similar to the drug modafinil. Taking modafinil with MAOIs has led to serious side effects. Some common MAOIs include phenelzine (Nardil), selegiline (Zelapar), and tranylcypromine (Parnate).
- Warfarin (Coumadin) interacts with AdrafinilAdrafinil has effects similar to the drug modafinil. Taking modafinil with warfarin might change the effects and side effects of warfarin. You warfarin dose might need to be changed.
- Medications for high blood pressure (Antihypertensive drugs) interacts with AdrafinilAdrafinil might increase blood pressure. Taking adrafinil might reduce the effects of blood pressure medications. Monitor your blood pressure closely.
- Medications changed by the liver (Cytochrome P450 1A2 (CYP1A2) substrates) interacts with AdrafinilSome medications are changed and broken down by the liver. Adrafinil might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
- Medications changed by the liver (Cytochrome P450 2B6 (CYP2B6) substrates) interacts with AdrafinilSome medications are changed and broken down by the liver. Adrafinil might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
- Medications changed by the liver (Cytochrome P450 2C19 (CYP2C19) substrates) interacts with AdrafinilSome medications are changed and broken down by the liver. Adrafinil might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
- Medications changed by the liver (Cytochrome P450 2C9 (CYP2C9) substrates) interacts with AdrafinilSome medications are changed and broken down by the liver. Adrafinil might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
- Medications that decrease break down of other medications in the liver (Cytochrome P450 3A4 (CYP3A4) inhibitors) interacts with AdrafinilAdrafinil is changed and broken down by the liver. Some drugs decrease how quickly the liver changes and breaks down adrafinil. This could change the effects and side effects of adrafinil.
- Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates) interacts with AdrafinilSome medications are changed and broken down by the liver. Adrafinil might change how quickly the liver breaks down these medications. This could change the effects and side effects of these medications.
- Stimulant drugs interacts with AdrafinilStimulant drugs speed up the nervous system. By speeding up the nervous system, stimulant medications can make you feel jittery and speed up your heartbeat. Adrafinil might also speed up the nervous system. Taking adrafinil along with stimulant drugs might increase the risk for serious heart or psychiatric effects.
Dosing
There isn't enough reliable information to know what an appropriate dose of adrafinil might be. It might also be unsafe. Speak with your healthcare provider before use.
References
- The 2015 Prohibited List, International Standard, World Anti-Doping Agency, 2015. https://wada-main-prod.s3.amazonaws.com/resources/files/wada-2015-prohibited-list-en.pdf. Accessed April 22, 2015.
- Urban AE, Cubala WJ. The role of eugeroics in the treatment of affective disorders. Psychiatr Pol. 2020;54(1):21-33.
- Lowe DW, Dobson E, Jewett AG, Whisler EE. Adrafinil: Psychostimulant and purported nootropic? Am J Psych Res J. 2021;17(1):7-9.
- Thobois S, Xie J, Mollion H, Benatru I, Broussolle E. Adrafinil-induced orofacial dyskinesia. Mov Disord 2004;19(8):965-6.
- Lu J, Wang X, Yang S, et al. Doping control analysis for adrafinil and its major metabolites in human urine. Rapid Commun Mass Spectrom 2009;23(11):1592-600.
- Chariot J, Appia F, Vaille C, Rozé C. Effect of modafinil on pancreatic exocrine secretion in rats. A comparison with adrafinil and related drugs. Fundam Clin Pharmacol 1987;1(4):243-52.
- Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs. 2008;68(13):1803-39.
- Provigil (modafinil) [package insert]. North Wales, PA: Teva Pharmaceuticals USA, Inc. Published: January 2015. Accessed on: Nov 11, 2022.
- Kinslow, CJ, Shapiro SD, Grunebaum MF, Miller EC. Acute hypertensive crisis and severe headache after concurrent use of armodafinil and tranylcypromine: Case report and review of the literature. Clinical Short Communication. October 2018; 393:1-3.